CANTON, Mass., March 17 /PRNewswire/ - Organogenesis, Inc., announced today that Damien Bates, MD, PhD, FRACS (Plast.), has joined the company as vice president of medical affairs.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM095)
Dr. Bates combines more than twelve years of surgical practice with solid regenerative medicine industry experience. He has practiced in orthopedic, dermatologic, vascular, oncologic and general surgery, infectious diseases and intensive care, both in the U.S. and Australia. An accomplished board-certified plastic and reconstructive surgeon, Dr. Bates will serve an important and multi-faceted role within Organogenesis. In addition to leading the company's clinical study department, Dr. Bates will strengthen Organogenesis' links to the surgical community. He will also impact patient lives by collaborating with Organogenesis research and development teams to guide new product development from lab science through to approved products.
"This is an exciting time for Organogenesis, and Damien's appointment serves to solidify our executive team," said Geoff MacKay, chief executive officer of Organogenesis. "Damien's wealth of experience in tissue engineering, stem cell biology and surgical wound healing is a great fit for Organogenesis as we grow our company, as well as our product pipeline."
Organogenesis is in the midst of a large expansion, both in employees as well as facilities, and also recently acquired the electro-spinning platform technology company NanoMatrix. The company is currently developing a number of new products, and recently launched the first-ever direct-to-consumer (DTC) educational campaign for a living cell therapy (its flagship product Apligraf(R)).
Prior to joining Organogenesis, Dr. Bates served as attending plastic
and reconstructive surgeon for the University of Colorado, The Children's
a
'/>"/>
| SOURCE Organogenesis, Inc. Copyright©2008 PR Newswire. All rights reserved |